Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

BSA Behavioral Health announced it is expanding its mental health services to include Spravato (esketamine) nasal spray, for ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

Ketamine seems to be everywhere — from the nightclub to the psychiatric clinic. Among its growing number of users is Elon Musk, who says he takes ketamine every two weeks for depression as prescribed ...

However, they may cover the FDA-approved nasal spray, Spravato, which contains a derivative of ketamine called esketamine. This article examines Medicare coverage for ketamine infusion, coverage ...

Original Medicare covers infusions that a healthcare professional administers. However, it does not generally cover ketamine infusions for mental health conditions such as depression and anxiety ...

A futuristic fix for depression is here — and it doesn’t involve prescription drugs or a shrink. The first-of-its-kind solution from GrayMatters Health uses something called “self ...

The result is a rearrangement of an individual’s relationship with anxiety and depression, he noted. “We have thought for a long time about psychiatric drugs in terms of symptom suppression.